Can psychedelics have a role in psychiatry once again?
The British Journal of Psychiatry June 1, 2005 DOI: 10.1192/bjp.186.6.457
Summary
Ancient wisdom meets modern science: Hallucinogens like Mescaline (a Phenethylamine), Psilocybin, and Lysergic acid derivatives such as Lysergic acid diethylamide (LSD) have been used for thousands of years. Contemporary Psychology and Psychedelics and Drug Studies now investigate their profound Neurotransmitter Receptor Influence on Behavior, with MDMA showing promise for Treatment of Major Depression. This field explores their therapeutic potential and mechanisms.
Abstract
Psychedelic or hallucinogenic drugs such as lysergic acid diethylamide (LSD), 3, 4, 5-trimethoxy-β-phenethylamine (mescaline), psilocybin, 3, 4-methylenedioxymethamph-etamine (MDMA), N, N-dimethyltrypta-mine (DMT) and their relations occur in abundance throughout the natural world, and have been used by humankind for thousands of years.